Darren R. Feldman, MD, details early response and disease control findings with a claudin 6–directed antibody-drug conjugate in relapsed germ cell tumors.
Darren R Feldman, MD
Advertisement
Articles by Darren R Feldman, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Sacituzumab Govitecan Triplet Elicits Durable Responses in Treatment-Naive Metastatic Urothelial Cancer
2
Perioperative Enfortumab Vedotin Plus Pembrolizumab Improves ctDNA Clearance in Cisplatin-Eligible MIBC
3
Pembrolizumab Plus Chemo Misses EFS End Point in Cisplatin-Eligible MIBC
4
Atirmociclib Plus Fulvestrant Improves PFS in HR+/HER2– Advanced Breast Cancer
5